BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28374498)

  • 1. Utility of GATA3 in the differential diagnosis of pheochromocytoma.
    Perrino CM; Ho A; Dall CP; Zynger DL
    Histopathology; 2017 Sep; 71(3):475-479. PubMed ID: 28374498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma.
    Kimura N; Shiga K; Kaneko K; Sugisawa C; Katabami T; Naruse M
    Endocr Pathol; 2020 Jun; 31(2):95-100. PubMed ID: 32303954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients.
    Elmoneim HM; Samaka RM; Ali H
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):462-9. PubMed ID: 22417854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA3 expression in benign prostate glands with radiation atypia: a diagnostic pitfall.
    Tian W; Dorn D; Wei S; Sanders RD; Matoso A; Shah RB; Gordetsky J
    Histopathology; 2017 Jul; 71(1):150-155. PubMed ID: 28316088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
    Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
    Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors].
    Feng C; Li HZ; Yan WG; Luo YF; Cao JL
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):486-8. PubMed ID: 16188147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA3 immunohistochemical expression in salivary gland neoplasms.
    Schwartz LE; Begum S; Westra WH; Bishop JA
    Head Neck Pathol; 2013 Dec; 7(4):311-5. PubMed ID: 23604756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
    Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
    J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant adrenal tumors.
    Rescorla FJ
    Semin Pediatr Surg; 2006 Feb; 15(1):48-56. PubMed ID: 16458846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
    Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
    Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong androgen receptor expression can aid in distinguishing GATA3+ metastases.
    Boto A; Harigopal M
    Hum Pathol; 2018 May; 75():63-70. PubMed ID: 29408697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases.
    Duregon E; Volante M; Bollito E; Goia M; Buttigliero C; Zaggia B; Berruti A; Scagliotti GV; Papotti M
    Hum Pathol; 2015 Dec; 46(12):1799-807. PubMed ID: 26472162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA3 staining in primary cutaneous apocrine cribriform carcinoma: Usefulness to differentiate it from breast cancer metastasis.
    Llamas-Velasco M; Pérez-Gónzalez YC; Daudén E; Rütten A
    J Cutan Pathol; 2018 May; 45(5):348-351. PubMed ID: 29431200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung.
    Berg KB; Churg A
    Am J Surg Pathol; 2017 Sep; 41(9):1221-1225. PubMed ID: 28614203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms.
    Pardal J; Sundram U; Selim MA; Hoang MP
    Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA3 expression in triple-negative breast cancers.
    Byrne DJ; Deb S; Takano EA; Fox SB
    Histopathology; 2017 Jul; 71(1):63-71. PubMed ID: 28211079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sampling of the adrenal glands by endoscopic ultrasound-guided fine-needle aspiration.
    Stelow EB; Debol SM; Stanley MW; Mallery S; Lai R; Bardales RH
    Diagn Cytopathol; 2005 Jul; 33(1):26-30. PubMed ID: 15945088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
    Sangoi AR; McKenney JK
    Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of GATA3 in breast carcinomas: a review.
    Asch-Kendrick R; Cimino-Mathews A
    Hum Pathol; 2016 Feb; 48():37-47. PubMed ID: 26772397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.